Download PDF
Radiologie up2date 2024; 24(03): 217-223
DOI: 10.1055/a-2297-0605
How I do it

How I do it – MRT bei neurodegenerativen Erkrankungen mit führender Demenzsymptomatik – Workflow und Bildauswertung

Georg Gohla  ∗
,
Benjamin Bender
,
Tobias Lindig
› Further Information
Also available at
    Permissions and Reprints All articles of this category

Die zerebrale MRT hat einen hohen Stellenwert in der Demenzdiagnostik. Das Erkrankungsspektrum ist vielfältig und weist oft Überlappungen und Mischformen auf. Standardisierte spezifische neurodegenerative MRT-Protokolle sowohl mit visuellen, semiquantitativen als auch mit automatisierten, quantitativ-volumetrischen Auswertungen helfen dabei, globale und regionale Atrophiemuster zu erkennen und auch im Verlauf zu bewerten.

Publication History

Article published online:
20 September 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Hejl A, Høgh P, Waldemar G. Potentially reversible conditions in 1000 consecutive memory clinic patients. J Neurol Neurosurg Psychiatry 2002; 73: 390-394
    CrossrefPubMedSearch in Google Scholar
  • 2 Urbach H, Egger K. MRT bei neurodegenerativen Erkrankungen. Fortschr Neurol Psychiatr 2020; 88: 266-284
    Thieme ConnectPubMedSearch in Google Scholar
  • 3 Horger M, Gohla G, Bender B. et al. [Patterns of regional brain atrophy and quantification methods in different types of neurodegenerative diseases with leading dementia symptomatology]. Rofo 2023;
    Thieme ConnectPubMedSearch in Google Scholar
  • 4 Qiu C, De Ronchi D, Fratiglioni L. The epidemiology of the dementias: an update. Curr Opin Psychiatry 2007; 20: 380-385
    CrossrefPubMedSearch in Google Scholar
  • 5 Klöppel S, Peter J, Ludl A. et al. Applying Automated MR-Based Diagnostic Methods to the Memory Clinic: A Prospective Study. J Alzheimers Dis 2015; 47: 939-954
    CrossrefPubMedSearch in Google Scholar
  • 6 Weder ND, Aziz R, Wilkins K. et al. Frontotemporal dementias: a review. Ann Gen Psychiatry 2007; 6: 15
    CrossrefPubMedSearch in Google Scholar
  • 7 Rabinovici GD, Carrillo MC, Forman M. et al. Multiple comorbid neuropathologies in the setting of Alzheimer’s disease neuropathology and implications for drug development. Alzheimers Dement (N Y) 2017; 3: 83-91
    CrossrefPubMedSearch in Google Scholar
  • 8 Lopera F, Marino C, Chandrahas AS. et al. Resilience to autosomal dominant Alzheimer’s disease in a Reelin-COLBOS heterozygous man. Nat Med 2023; 29: 1243-1252
    CrossrefPubMedSearch in Google Scholar
  • 9 Sims JR, Zimmer JA, Evans CD. et al. Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial. JAMA 2023; 330: 512-527
    CrossrefPubMedSearch in Google Scholar
  • 10 Cohen S, van Dyck CH, Gee M. et al. Lecanemab Clarity AD: Quality-of-Life Results from a Randomized, Double-Blind Phase 3 Trial in Early Alzheimer’s Disease. J Prev Alzheimers Dis 2023; 10: 771-777
    CrossrefPubMedSearch in Google Scholar
  • 11 Gifford DR, Holloway RG, Vickrey BG. Systematic review of clinical prediction rules for neuroimaging in the evaluation of dementia. Arch Intern Med 2000; 160: 2855-2862
    CrossrefPubMedSearch in Google Scholar
  • 12 Dormont D, Seidenwurm DJ. Dementia and Movement Disorders. Am J Neurorad 2008; 29: 204-206
    PubMedSearch in Google Scholar
  • 13 Mathias JL, Burke J. Cognitive functioning in Alzheimer’s and vascular dementia: a meta-analysis. Neuropsych 2009; 23: 411-423
    CrossrefPubMedSearch in Google Scholar
  • 14 Targosz-Gajniak M, Siuda J, Ochudło S. et al. Cerebral white matter lesions in patients with dementia – from MCI to severe Alzheimer’s disease. J Neurol Sci 2009; 283: 79-82
    CrossrefPubMedSearch in Google Scholar
  • 15 Pasquier F, Leys D, Weerts JG. et al. Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol 1996; 36: 268-272
    CrossrefPubMedSearch in Google Scholar
  • 16 Scheltens P, Leys D, Barkhof F. et al. Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992; 55: 967-972
    CrossrefPubMedSearch in Google Scholar
  • 17 Enkirch SJ, Traschütz A, Müller A. et al. The ERICA Score: An MR Imaging-based Visual Scoring System for the Assessment of Entorhinal Cortex Atrophy in Alzheimer Disease. Radiology 2018; 288: 226-333
    CrossrefPubMedSearch in Google Scholar
  • 18 Koedam ELGE, Lehmann M, van der Flier WM. et al. Visual assessment of posterior atrophy development of a MRI rating scale. Eur Radiol 2011; 21: 2618-2625
    CrossrefPubMedSearch in Google Scholar
  • 19 Ferreira D, Cavallin L, Granberg T. et al. Quantitative validation of a visual rating scale for frontal atrophy: associations with clinical status, APOE e4, CSF biomarkers and cognition. Eur Radiol 2016; 26: 2597-2610
    CrossrefPubMedSearch in Google Scholar
  • 20 Dubois B, Feldman HH, Jacova C. et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol 2014; 13: 614-629
    CrossrefPubMedSearch in Google Scholar
  • 21 Elahi FM, Miller BL. A clinicopathological approach to the diagnosis of dementia. Nat Rev Neurol 2017; 13: 457-476
    CrossrefPubMedSearch in Google Scholar
  • 22 Duong MT, Wolk DA. Limbic-predominant Age-related TDP-43 Encephalopathy: LATE-Breaking Updates in Clinicopathologic Features and Biomarkers. Curr Neurol Neurosci Rep 2022; 22: 689-698
    CrossrefPubMedSearch in Google Scholar
  • 23 Whitwell JL, Jack CR, Kantarci K. et al. Imaging Correlates of Posterior Cortical Atrophy. Neurobiol Aging 2007; 28: 1051-1061
    CrossrefPubMedSearch in Google Scholar
  • 24 Shir D, Corriveau-Lecavalier N, Bermudez Noguera C. et al. Clinicoradiological and neuropathological evaluation of primary progressive aphasia. J Neurol Neurosurg Psychiatry 2024;
    CrossrefPubMedSearch in Google Scholar
  • 25 Hanseeuw BJ, Jacobs HIL, Schultz AP. et al. Association of Pathologic and Volumetric Biomarker Changes With Cognitive Decline in Clinically Normal Adults. Neurology 2023; 101: e2533-e2544
    CrossrefPubMedSearch in Google Scholar
  • 26 Román GC, Tatemichi TK, Erkinjuntti T. et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 250-260
    CrossrefPubMedSearch in Google Scholar
  • 27 Feldman HH, Jacova C, Robillard A. et al. Diagnosis and treatment of dementia: 2. Diagnosis. CMAJ 2008; 178: 825-836
    CrossrefPubMedSearch in Google Scholar
  • 28 Charidimou A, Boulouis G, Frosch MP. et al. The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study. Lancet Neurol 2022; 21: 714-725
    CrossrefPubMedSearch in Google Scholar
  • 29 McKeith IG, Boeve BF, Dickson DW. et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 2017; 89: 88-100
    CrossrefPubMedSearch in Google Scholar
  • 30 Constantinides VC, Paraskevas GP, Paraskevas PG. et al. Corticobasal degeneration and corticobasal syndrome: A review. Clin Park Relat Disord 2019; 1: 66-71
    CrossrefPubMedSearch in Google Scholar
  • 31 Gorno-Tempini ML, Hillis AE, Weintraub S. et al. Classification of primary progressive aphasia and its variants. Neurology 2011; 76: 1006-1014
    CrossrefPubMedSearch in Google Scholar
  • 32 Rascovsky K, Hodges JR, Knopman D. et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011; 134: 2456-2477
    CrossrefPubMedSearch in Google Scholar